FCM
JAZZ icon

Fieldview Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fieldview Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$643K Sell
3,400
-7,567
-69% -$1.32M 0.19% 186
2025
Q4 		$1.86M Buy
+10,967
New +$1.68M 0.32% 107
2025
Q2 		– Sell
-43,462
Closed -$5.4M – 437
2025
Q1 		$5.4M Buy
43,462
+12,610
+41% +$1.65M 0.76% 22
2024
Q4 		$3.8M Buy
+30,852
New +$3.64M 0.59% 48

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fieldview Capital Management's JAZZ Position: Q1 2026 in Review

Fieldview Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 69% in Q1 2026, selling an estimated $1.32M and leaving 3,400 shares worth $643K. The position accounts for 0.19% of the portfolio, ranked #186.

Fieldview Capital Management first reported a position in JAZZ in Q4 2024 and has held it in 4 quarters since. The position peaked at $5.4M in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Fieldview Capital Management held 3,400 shares of Jazz Pharmaceuticals worth $643K as of Q1 2026.
  • Fieldview Capital Management sold 7,567 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.32M.
  • Jazz Pharmaceuticals made up 0.19% of Fieldview Capital Management's portfolio in Q1 2026, its #186 holding.
  • Fieldview Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Fieldview Capital Management's Jazz Pharmaceuticals position peaked at $5.4M in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.